Tuberculosis Drug Susceptibility, Treatment, and Outcomes for Belarusian HIV-Positive Patients with Tuberculosis: Results from a National and International Laboratory

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Tuberculosis Drug Susceptibility, Treatment, and Outcomes for Belarusian HIV-Positive Patients with Tuberculosis: Results from a National and International Laboratory. / Podlekareva, Daria N.; Folkvardsen, Dorte Bek; Skrahina, Alena; Vassilenko, Anna; Skrahin, Aliaksandr; Hurevich, Henadz; Klimuk, Dzmitry; Karpov, Igor; Lundgren, Jens D.; Kirk, Ole; Lillebaek, Troels; Drlica, Karl (Redaktør).

I: Tuberculosis research and treatment, Bind 2021, 6646239 , 02.04.2021, s. 1-13.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Podlekareva, DN, Folkvardsen, DB, Skrahina, A, Vassilenko, A, Skrahin, A, Hurevich, H, Klimuk, D, Karpov, I, Lundgren, JD, Kirk, O, Lillebaek, T & Drlica, K (red.) 2021, 'Tuberculosis Drug Susceptibility, Treatment, and Outcomes for Belarusian HIV-Positive Patients with Tuberculosis: Results from a National and International Laboratory', Tuberculosis research and treatment, bind 2021, 6646239 , s. 1-13. https://doi.org/10.1155/2021/6646239

APA

Podlekareva, D. N., Folkvardsen, D. B., Skrahina, A., Vassilenko, A., Skrahin, A., Hurevich, H., Klimuk, D., Karpov, I., Lundgren, J. D., Kirk, O., Lillebaek, T., & Drlica, K. (red.) (2021). Tuberculosis Drug Susceptibility, Treatment, and Outcomes for Belarusian HIV-Positive Patients with Tuberculosis: Results from a National and International Laboratory. Tuberculosis research and treatment, 2021, 1-13. [6646239 ]. https://doi.org/10.1155/2021/6646239

Vancouver

Podlekareva DN, Folkvardsen DB, Skrahina A, Vassilenko A, Skrahin A, Hurevich H o.a. Tuberculosis Drug Susceptibility, Treatment, and Outcomes for Belarusian HIV-Positive Patients with Tuberculosis: Results from a National and International Laboratory. Tuberculosis research and treatment. 2021 apr. 2;2021:1-13. 6646239 . https://doi.org/10.1155/2021/6646239

Author

Podlekareva, Daria N. ; Folkvardsen, Dorte Bek ; Skrahina, Alena ; Vassilenko, Anna ; Skrahin, Aliaksandr ; Hurevich, Henadz ; Klimuk, Dzmitry ; Karpov, Igor ; Lundgren, Jens D. ; Kirk, Ole ; Lillebaek, Troels ; Drlica, Karl (Redaktør). / Tuberculosis Drug Susceptibility, Treatment, and Outcomes for Belarusian HIV-Positive Patients with Tuberculosis: Results from a National and International Laboratory. I: Tuberculosis research and treatment. 2021 ; Bind 2021. s. 1-13.

Bibtex

@article{b22159513e7f4aa39b15548799f07cfa,
title = "Tuberculosis Drug Susceptibility, Treatment, and Outcomes for Belarusian HIV-Positive Patients with Tuberculosis: Results from a National and International Laboratory",
author = "Podlekareva, {Daria N.} and Folkvardsen, {Dorte Bek} and Alena Skrahina and Anna Vassilenko and Aliaksandr Skrahin and Henadz Hurevich and Dzmitry Klimuk and Igor Karpov and Lundgren, {Jens D.} and Ole Kirk and Troels Lillebaek and Karl Drlica",
year = "2021",
month = apr,
day = "2",
doi = "10.1155/2021/6646239",
language = "English",
volume = "2021",
pages = "1--13",
journal = "Tuberculosis research and treatment",
issn = "2090-150X",
publisher = "Hindawi",

}

RIS

TY - JOUR

T1 - Tuberculosis Drug Susceptibility, Treatment, and Outcomes for Belarusian HIV-Positive Patients with Tuberculosis: Results from a National and International Laboratory

AU - Podlekareva, Daria N.

AU - Folkvardsen, Dorte Bek

AU - Skrahina, Alena

AU - Vassilenko, Anna

AU - Skrahin, Aliaksandr

AU - Hurevich, Henadz

AU - Klimuk, Dzmitry

AU - Karpov, Igor

AU - Lundgren, Jens D.

AU - Kirk, Ole

AU - Lillebaek, Troels

A2 - Drlica, Karl

PY - 2021/4/2

Y1 - 2021/4/2

U2 - 10.1155/2021/6646239

DO - 10.1155/2021/6646239

M3 - Journal article

C2 - 33868727

VL - 2021

SP - 1

EP - 13

JO - Tuberculosis research and treatment

JF - Tuberculosis research and treatment

SN - 2090-150X

M1 - 6646239

ER -

ID: 281107728